Advanced search
Publication Cover
Clinical Toxicology Volume 56, 2018 - Issue 11
Submit an article Journal homepage
432
Views
17
CrossRef citations to date
0
Altmetric
Clinical Research

Acute adverse events associated with the administration of Crotalidae polyvalent immune Fab antivenom within the North American Snakebite Registry

Kurt KleinschmidtDepartment of Emergency Medicine, Division of Medical Toxicology, University of Texas Southwestern Medical Center, Dallas, TX, USA; Correspondence[email protected]
View further author information
,
Anne-Michelle RuhaDivision of Medical Toxicology and Precision Medicine, University of Arizona College of Medicine, Phoenix, AZ, USA; View further author information
,
Sharan CamplemanAmerican College of Medical Toxicology, Phoenix, AZ, USA; View further author information
,
Jeffrey BrentDistinguished Clinical Professor of Medicine, University of Colorado School of Medicine, Denver, CO, USAView further author information
,
Paul WaxDepartment of Emergency Medicine, Division of Medical Toxicology, University of Texas Southwestern Medical Center, Dallas, TX, USA; View further author information
& On Behalf of the ToxIC North American Snakebite Registry Group
Pages 1115-1120 | Received 15 Sep 2017, Accepted 08 Apr 2018, Published online: 24 Apr 2018

References

  • Seifert SA, Boyer LV, Benson BE, et al. AAPCC database characterization of native U.S. venomous snake exposures, 2001-2005. Clin Toxicol. 2009;47:327–335.
  • Mowry JB, Spyker DA, Brooks DE, et al. 2014 annual report of the American Association of Poison Control Centers' National Poison Data System (NPDS): 32nd annual report. Clin Toxicol. 2015;53:962–1147.
  • Offerman SR, Smith TS, Derlet RW. Does the aggressive use of polyvalent antivenin for rattlesnake bites result in serious acute side effects? West J Med. 2001;175:88–91.
  • Jurkovich GJ, Luterman A, McCullar K, et al. Complications of Crotalidae antivenin therapy. J Trauma. 1988;28:1032–1037.
  • Tanen D, Ruha A, Graeme K, et al. Epidemiology and hospital course of rattlesnake envenomations cared for at a tertiary referral center in Central Arizona. Acad Emergency Med. 2001;8:177–182.
  • Clark RF, McKinney PE, Chase PB, et al. Immediate and delayed allergic reactions to Crotalidae polyvalent immune Fab (ovine) antivenom. Ann Emerg Med. 2002;39:671–676.
  • Dart RC, Seifert SA, Carroll L, et al. Affinity-purified, mixed monospecific crotalid antivenom ovine Fab for the treatment of crotalid venom poisoning. Ann Emerg Med. 1997;30:33–39.
  • Lepak MR, Bochenek SH, Bush SP. Severe adverse drug reaction following Crotalidae Polyvalent Immune Fab (Ovine) administration for copperhead snakebite. Ann Pharmacother. 2015;49:145–149.
  • Dart RC, Seifert SA, Boyer LV, et al. A randomized multicenter trial of crotalinae polyvalent immune Fab (ovine) antivenom for the treatment for crotaline snakebite in the United States. Arch Intern Med. 2001;161:2030–2036.
  • Bush SP, Green SM, Moynihan JA, et al. Crotalidae polyvalent immune Fab (ovine) antivenom is efficacious for envenomations by Southern Pacific rattlesnakes (Crotalus helleri). Ann Emerg Med. 2002;40:619–624.
  • Lavonas EJ, Kokko J, Schaeffer TH, et al. Short-term outcomes after Fab antivenom therapy for severe crotaline snakebite. Ann Emerg Med. 2011;57:128–137.
  • Ruha AM, Curry SC, Beuhler M, et al. Initial postmarketing experience with crotalidae polyvalent immune Fab for treatment of rattlesnake envenomation. Ann Emerg Med. 2002;39:609–615.
  • Cannon R, Ruha AM, Kashani J. Acute hypersensitivity reactions associated with administration of crotalidae polyvalent immune Fab antivenom. Ann Emerg Med. 2008;51:407–411.
  • Corneille MG, Larson S, Stewart RM, et al. A large single-center experience with treatment of patients with crotalid envenomations: outcomes with and evolution of antivenin therapy. Am J Surg. 2006;192:848–852.
  • Lavonas EJ, Gerardo CJ, O'Malley G, et al. Initial experience with Crotalidae polyvalent immune Fab (ovine) antivenom in the treatment of copperhead snakebite. Ann Emerg Med. 2004;43:200–206.
  • Nazim MH, Gupta S, Hashmi S, et al. Retrospective review of snake bite victims. W V Med J. 2008;104:30–34.
  • Farrar HC, Grayham T, Bolden B, et al. The use and tolerability of Crotalidae Polyvalent Immune FAB (Ovine) in pediatric envenomations. Clin Pediatr. 2012;51:945–949.
  • Offerman SR, Bush SP, Moynihan JA, et al. Crotaline Fab antivenom for the treatment of children with rattlesnake envenomation. Pediatrics. 2002;110:968–971.
  • Pizon AF, Riley BD, LoVecchio F, et al. Safety and efficacy of Crotalidae Polyvalent Immune Fab in pediatric crotaline envenomations. Acad Emerg Med. 2007;14:373–376.
  • Schaeffer TH, Khatri V, Reifler LM, et al. Incidence of immediate hypersensitivity reaction and serum sickness following administration of Crotalidae polyvalent immune Fab antivenom: a meta-analysis. Acad Emerg Med. 2012;19:121–131.
  • Weinger MB, Slagle J, Jain S, et al. Retrospective data collection and analytical techniques for patient safety studies. J Biomed Inform. 2003;36:106–119.
  • Wax PM, Kleinschmidt KC, Brent J. The Toxicology Investigators Consortium (ToxIC) registry. J Med Toxicol. 2011;7:259–265.
  • Farrugia LA, Rhyee SH, Campleman SL, et al. The toxicology investigators consortium case registry – the 2015 experience. J Med Toxicol. 2016;12:224–247.
  • Spiller HA, Bosse GM, Ryan ML. Use of antivenom for snakebites reported to United States poison centers. Am J Emerg Med. 2010;28:780–785.
  • Commins SP. Outpatient emergencies: anaphylaxis. Med Clin North Am. 2017;101:521–536.
  • Naranjo CA, Busto U, Sellers EM, et al. A method for estimating the probability of adverse drug reactions. Clin Pharmacol Ther. 1981;30:239–245.
  • Holstege CP, Wu J, Baer AB. Immediate hypersensitivity reaction associated with the rapid infusion of Crotalidae polyvalent immune Fab (ovine). Ann Emerg Med. 2002;39:677–679.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.